We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+13.76%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$61.1B
AUM Growth
+$6.8B
(+13%)
Cap. Flow
-$1.88B
Cap. Flow
% of AUM
-3.07%
Top 10 Holdings %
Top 10 Hldgs %
23.3%
Holding
1,241
New
198
Increased
365
Reduced
338
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intercontinental Exchange
ICE
|
+$348M |
| 2 |
Elanco Animal Health
ELAN
|
+$327M |
| 3 |
Norfolk Southern
NSC
|
+$273M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$258M |
| 5 |
Medtronic
MDT
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$490M |
| 2 |
CHL
China Mobile Limited
CHL
|
+$445M |
| 3 |
Edison International
EIX
|
+$392M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$384M |
| 5 |
RTX Corp
RTX
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.22% |
| 2 | Healthcare | 15.06% |
| 3 | Financials | 13.35% |
| 4 | Industrials | 12.52% |
| 5 | Communication Services | 11.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEF
301
abrdn Emerging Markets Equity Income Fund
AEF
$356M
| $16M | 0.03% |
2,201,623
-7,100
| -0.3% | -$50.2K |
|
302
Vertex Pharmaceuticals
VRTX
$121B
| $15.9M | 0.03% |
86,227
+53,177
| +161% | +$9.82M |
|
303
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
| $15.6M | 0.03% |
301,950
+96,297
| +47% | +$4.88M |
|
304
Pegasystems
PEGA
$5.02B
| $15.2M | 0.02% |
+468,018
| New | +$13.8M |
|
|
FITB
305
Fifth Third Bancorp
FITB
$51.2B
| $15M | 0.02% |
596,430
+63,480
| +12% | +$1.69M |
|
306
PayPal
PYPL
$48.9B
| $15M | 0.02% |
144,214
+25,113
| +21% | +$2.38M |
|
307
Essential Properties Realty Trust
EPRT
$6.77B
| $14.8M | 0.02% |
760,809
+647,981
| +574% | +$10.6M |
|
|
EV
308
DELISTED
Eaton Vance Corp.
EV
| $14.8M | 0.02% |
+365,932
| New | +$14.5M |
|
309
Costco
COST
$422B
| $14.7M | 0.02% |
60,914
-62,612
| -51% | -$13.7M |
|
310
Ulta Beauty
ULTA
$22B
| $14.4M | 0.02% |
+41,240
| New | +$12.5M |
|
311
Grupo Aeroportuario del Pacifico
PAC
$12.9B
| $14.4M | 0.02% |
161,525
+20,400
| +14% | +$1.84M |
|
312
Xcel Energy
XEL
$48.8B
| $14.4M | 0.02% |
255,378
-34,168
| -12% | -$1.82M |
|
313
Sabesp
SBS
$19.1B
| $14.3M | 0.02% |
6,964,203
-1,296,330
| -16% | -$2.7M |
|
314
Lamb Weston
LW
$7.22B
| $14.2M | 0.02% |
188,998
-290,168
| -61% | -$20.5M |
|
315
Tenaris
TS
$28.9B
| $14.1M | 0.02% |
499,156
+88,510
| +22% | +$2.28M |
|
316
Keysight
KEYS
$54.5B
| $14M | 0.02% |
160,471
+103,269
| +181% | +$8.02M |
|
317
Norwegian Cruise Line
NCLH
$8.51B
| $13.9M | 0.02% |
253,391
+26,268
| +12% | +$1.35M |
|
318
ASE Group
ASX
$77.3B
| $13.9M | 0.02% |
3,220,545
-2,630,563
| -45% | -$10.3M |
|
319
Gilead Sciences
GILD
$162B
| $13.9M | 0.02% |
213,488
+44,885
| +27% | +$2.98M |
|
320
Take-Two Interactive
TTWO
$45.4B
| $13.9M | 0.02% |
146,960
+131,913
| +877% | +$12.8M |
|
321
Micron Technology
MU
$930B
| $13.8M | 0.02% |
334,359
+46,177
| +16% | +$1.78M |
|
322
Utah Medical Products
UTMD
$225M
| $13.7M | 0.02% |
155,262
-32,100
| -17% | -$2.82M |
|
323
Transportadora de Gas del Sur
TGS
$4.79B
| $13.6M | 0.02% |
1,072,379
-186,676
| -15% | -$2.73M |
|
324
Leidos
LDOS
$14.5B
| $13.5M | 0.02% |
211,245
+56,885
| +37% | +$3.43M |
|
325
CAE Inc. Common Shares
CAE
$8.3B
| $13.4M | 0.02% |
606,691
-3,680
| -0.6% | -$77K |
|
Similar funds
QCM
Lazard Asset Management's Q1 2019 Portfolio in Review
As of Q1 2019, Lazard Asset Management held 1,241 positions worth $61.1B, up 13% from $54.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $1.88B in Q1 2019, closing 99 positions and reducing 338 holdings. Its most notable exit was PG&E, an estimated $490M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Elanco Animal Health worth $341M.
- Lazard Asset Management's largest Q1 2019 buy was Elanco Animal Health: 10,640,964 shares worth $341M.
- Lazard Asset Management added most to Intercontinental Exchange in Q1 2019, an estimated $348M increase.
- Lazard Asset Management's biggest Q1 2019 reduction was China Mobile Limited, cutting an estimated $445M.
- Lazard Asset Management fully exited PG&E in Q1 2019, selling an estimated $490M.
- Lazard Asset Management's ten largest holdings make up 23% of its $61.1B portfolio in Q1 2019.
- Lazard Asset Management opened 198 new positions and closed 99 in Q1 2019.
- Lazard Asset Management's portfolio value rose 13% quarter-over-quarter to $61.1B.
Based on Lazard Asset Management's 13F filing for Q1 2019, filed 13 May 2019.